China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.
CPHI stock price ended at $0.91 on 木曜日, after dropping 9.00%
On the latest trading day May 14, 2026, the stock price of CPHI fell by 9.00%, dropping from $0.88 to $0.91. During the session, the stock saw a volatility of 10.47%, with prices oscillating between a daily low of $0.86 and a high of $0.95. On the latest trading day, the trading volume for CPHI decreased by 692.3K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 38.0K shares were traded, with a market value of approximately $36.8M.